Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide
US7875585B2 · kind B2 · utility
9Cited by
4References
11Claims
0Family size
Inventor
Key dates
| Filing date | Oct 18, 2001 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Apr 4, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention feature methods and compositions for treating hematopoietic disorders, inflammatory conditions, and cancer and providing stem cell therapy in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.